Overview
Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).
Status:
Unknown status
Unknown status
Trial end date:
2016-08-01
2016-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Compare different corneal parameters and visual outcome of corneal collagen cross-linking (CXL) with conventional versus accelerated ultraviolet-A irradiation using riboflavin with hydroxypropyl methylcellulose.Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Oslo University HospitalTreatments:
Riboflavin
Criteria
Inclusion Criteria:- Patients with increase of minimum of 1,0 diopter in maximum keratometry.
- Patients with increase in corneal astigmatism of minimum 1,0 diopter.
- Patients with in spherical equivalent of min 0,5 diopter.
- Patients living in Eastern Norway.
Exclusion Criteria:
- Minimum pachymetric corneal thickness (Pentacam)<360 µm.
- Central corneal scar.
- Chemical burn, serious corneal infections and ocular surface diseases.
- Pregnancy.
- Lactation.